Premenopausal
10
2
4
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
80.0%
-6.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (10)
Oxytocin in Postmenopausal Women
The Influence of Plan B® on Cardiovascular Health.
Comprehensive Lifestyle Change To Prevent Breast Cancer
Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
Validation of [18F]FES for Imaging of Brain Estrogen Receptors
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients